Lipid metabolism and coagulation of two contraceptives: Correlation to serum concentrations of levonorgestrel and gestodene
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 40 (6) , 665-673
- https://doi.org/10.1016/0010-7824(89)90070-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosisAmerican Heart Journal, 1987
- Measurement of total HDL, HDL2 and HDL3 by dextran sulfate—MgCl2 precipitation technique in human serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986
- Oral contraceptives and blood coagulation: A critical reviewAmerican Journal of Obstetrics and Gynecology, 1982
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977